(Q40705749)

English

Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma.

scientific article published on 5 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

based on heuristic

inferred from title

tumor progression

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Andrew Yu-Keat Khor

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ying Toh

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

John Carson Allen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

David Chee-Eng Ng

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Yung-Hsiang Kao

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Guili Zhu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Richard Hoau-Gong Lo

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Kiang-Hiong Tay

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Jin-Yao Teo

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Brian Kim-Poh Goh

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Mark Christiaan Burgmans

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Farah Gillian Irani

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Anthony Soon-Whatt Goh

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

5 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Hepatology international

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

395-404

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26202641%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

https://scigraph.springernature.com/pub.10.1007/s12072-014-9533-9

0 references

Primary liver cancer: worldwide incidence and trends

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: a review.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Hepatic toxicity resulting from cancer treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Radioembolization for hepatocellular carcinoma: a review of the evidence and treatment recommendations.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma: a systematic review.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Current strategy for staging and treatment: the BCLC update and future prospects.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Technical aspects of radioembolization with 90Y microspheres.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Radioembolization for the treatment of liver tumors general principles.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

1 reference

https://api.crossref.org/works/10.1007%2FS12072-014-9533-9

21 January 2018

Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26202641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma--epidemiological trends and risk factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/26202641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres

1 reference

https://pubmed.ncbi.nlm.nih.gov/26202641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/26202641

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40705749&oldid=2070831263"